Top Stories Of 2007: From Talk Of BTC To Supplement GMPs
This article was originally published in The Tan Sheet
Executive Summary
The past year offered anticipated changes and moves as well as some unexpected thrills and chills for the nonprescription drugs and nutritional products industries
You may also be interested in...
FDA Advisors Say Greater Insight Needed On Self-Selection Of OTC Statins
More information from "real world" experiences on how consumers make OTC selections may be needed to pull off a successful Rx-to-OTC switch of a statin
Waxman Bill Would Alter OTC Ad Rules, Streamline FDA Monograph Authority
Democrats are seeking to significantly increase FDA authority over over-the-counter drug monographs and potentially change the face of OTC advertising, prompted by recent high-profile concerns over pediatric cough/cold medications
Biden DXM Bill Includes Age Limit, Bulk Ingredient Scheduling
The Consumer Healthcare Products Association backs Sen. Joe Biden's proposal to set a nationwide age limit on purchases of dextromethorphan-containing OTC drugs, but the group differs with the bill's approach to regulating bulk sales of raw DXM